thiazolidines has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielicki, L; Hohorst, HJ; Voelcker, G | 1 |
| Bielicki, L; Hohorst, HJ; Müller, K; Voelcker, G | 1 |
2 other study(ies) available for thiazolidines and Leukemia P388
| Article | Year |
|---|---|
Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Leukemia P388; Male; Mast-Cell Sarcoma; Mice; Nitrogen Mustard Compounds; Prodrugs; Protein Binding; Thiazines; Thiazoles; Thiazolidines; Tissue Distribution | 1997 |
Low toxicity cancer chemotherapy by suicide inactivation of DNA polymerase alpha holoenzyme: first results with new thiazolidinyl- and perhydrothiazinyl-ethyl-N-mustard-phosphamide esters.
Topics: Animals; Antineoplastic Agents; DNA Polymerase II; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Nitrogen Mustard Compounds; Thiazines; Thiazoles; Thiazolidines | 1988 |